Largest positions
| Issuer | Class | Value | Share |
|---|---|---|---|
| Arrivent Biopharma, Inc..COM | COM | $51,928,866 | 27.5% |
| Parabilis Medicines, Inc..COM | COM | $43,817,646 | 23.2% |
| Maplebear, Inc..COM | COM | $33,652,166 | 17.9% |
| Maze Therapeutics, Inc..COM | COM | $30,911,554 | 16.4% |
| Odyssey Therapeutics, Inc..COMMON STOCK | COMMON STOCK | $15,160,189 | 8.0% |
| Eikon Therapeutics, Inc..COM | COM | $3,983,291 | 2.1% |
| Fractyl Health, Inc..COM | COM | $3,879,997 | 2.1% |
| Ethos Technologies, Inc..CL A | CL A | $1,345,607 | 0.7% |
| Coupang Inc..CL A | CL A | $949,739 | 0.5% |
| Amazon.com Inc..COM | COM | $925,236 | 0.5% |
| Meta Platforms Inc..CL A | CL A | $743,543 | 0.4% |
| Doordash Inc..CL A | CL A | $525,911 | 0.3% |
| Carvana CoCL A | CL A | $425,526 | 0.2% |
| Figma, Inc..CLASS A COM STK | CLASS A COM STK | $268,546 | 0.1% |
- Class
- COM
- Share
- 27.5%
- Class
- COM
- Share
- 23.2%
- Class
- COM
- Share
- 17.9%
- Class
- COM
- Share
- 16.4%
- Class
- COMMON STOCK
- Share
- 8.0%
- Class
- COM
- Share
- 2.1%
- Class
- COM
- Share
- 2.1%
- Class
- CL A
- Share
- 0.7%
- Class
- CL A
- Share
- 0.5%
- Class
- COM
- Share
- 0.5%
- Class
- CL A
- Share
- 0.4%
- Class
- CL A
- Share
- 0.3%
- Class
- CL A
- Share
- 0.2%
- Class
- CLASS A COM STK
- Share
- 0.1%
The share class is shown on a wider screen.
The 14 largest of 14 positions by value, with holdings of the same security combined. Share counts and quarter-on-quarter changes for each position are on EDGAR. View the full information table on EDGAR
This filing
- Form
- 13F-HR
- CIK
- 1637946
- File number
- 028-18372
- Options
- 0 call, 0 put
- In the 25 largest
- 100.0%
- Prior quarter
- $183,563,493 at 31 March 2026
- Positions opened
- 4
- Positions closed
- 2
Common questions
What are General Catalyst Group Management’s 13F holdings worth?
$188,517,817 across 14 positions for the quarter ended 30 June 2026.
What is General Catalyst Group Management’s largest 13F holding?
ArriVent BioPharma, Inc. (COM) was the largest position at $51,928,866, or 27.5% of reported 13F value, as of 30 June 2026.
How concentrated is General Catalyst Group Management’s 13F portfolio?
The ten largest positions accounted for 99.0% of reported value and the twenty-five largest for 100.0%, across 14 positions as of 30 June 2026.
Does Form 13F show everything General Catalyst Group Management manages?
No. Form 13F covers only long positions in exchange-traded securities over which the manager has investment discretion, valued at quarter end. It excludes cash, most bonds, private funds, and any assets the firm does not have discretion over, so it is neither the firm's total assets nor any individual client's portfolio.
How often does General Catalyst Group Management file its 13F?
Every quarter. Managers file within 45 days of each quarter's end, so the figures are a snapshot that changes between filings. This page shows the quarter ended 30 June 2026.
Answered from this filing and the prior quarter's.